Don’t MISS MIS-C: A Division-1 Athlete with a Possible Deadly Post-COVID Complication - Abstract
This case is about an 18-year-old African-American male, who is a division-I college football offensive lineman, with a history of asthma and obesity who presented to the
emergency department (ED) with fever and myalgias. The patient tested positive for COVID-19 approximately a month before during a routine screening and was asymptomatic at
the time. The patient presented to the ED with 2 days of fever, headache, myalgias, and generalized weakness. His labs showed he had markedly elevated inflammatory markers,
a transaminitis, and thrombocytopenia. He also had new T-wave inversions on his ECG. He was treated with prophylactic Lovenox due to his elevated D-dimer and risk for VTE. His
MIS-C was treated with IVIG 1 g/kg (max 80 g). His inflammatory markers decreased, his symptoms resolved and after a few days he was discharged from the hospital on ASA
81mg. He then did a progressive exercise program which included strict cardiac monitoring which he completed without issue. He returned to full football activity 4 weeks after his
initial diagnosis. This is the first known case of MIS-C in an elite college athlete. It is important to consider MIS-C in our younger athletes as a consequence of Covid-19 which may lead
to significant risk factors for their playing future. This disease process can be deadly and, in most cases, need admission to an intensive care unit. This case highlights the importance
of early diagnosis and treatment, as well as the various cardiac diagnostic modalities needed to assist with the return-to-play process